AI Article Synopsis
- FDG PET/CT is becoming more important for assessing urinary bladder cancer, but benign conditions can also cause increased FDG uptake.
- Urinary bladder leiomyomas are rare, benign tumors that account for less than 0.5% of bladder tumors.
- This study highlights the low-grade FDG uptake in a leiomyoma, suggesting it as a rare differential diagnosis for bladder cancer.
Article Abstract
F-Fluorodeoxyglucose-positron emission tomography/computed tomography (FDG PET/CT) has shown an increasing role in the evaluation of urinary bladder cancer, though benign pathological processes of the urinary bladder can also result in increased FDG uptake. Leiomyomas of urinary bladder are benign mesenchymal neoplasms and a very rare bladder tumor comprising <0.5% of all bladder tumors. Here, we present the low-grade FDG uptake in urinary bladder leiomyoma on PET/CT done for the clinical suspicion of bladder cancer, which can be a rare differential for bladder carcinoma.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6011574 | PMC |
| http://dx.doi.org/10.4103/ijnm.IJNM_40_18 | DOI Listing |
Publication Analysis
Top Keywords
urinary bladder
12
f-fluorodeoxyglucose-positron emission
8
emission tomography/computed
8
tomography/computed tomography
8
bladder
6
bladder leiomyoma
4
leiomyoma rare
4
rare differential
4
differential potential
4
potential pitfall
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!